UT SOUTHWESTERN MEDICAL CENTRE
Dr. Bishop received his medical degree from Texas Tech University followed by anatomic & clinical pathology training at The Johns Hopkins University. After residency, he joined the surgical pathology faculty at Johns Hopkins. In 2017, he joined the faculty of UT Southwestern Medical Center where he serves as the Jane B. and Edwin P. Jenevein M.D. Chair in Pathology and Director of Anatomic Pathology. Dr. Bishop has lectured and published extensively in the field of head & neck pathology, authoring >200 articles, 6 books, and numerous book chapters including 15 entries in the latest WHO Classification of Head and Neck Tumors. He is the lead author for the upcoming AFIP salivary gland fascicle. He is the editor-in-chief of Seminars in Diagnostic Pathology, an associate editor for Modern Pathology and JAMA-Otolaryngology-Head and Neck Surgery.
UNIVERSITY OF KENT
Tim is a Senior Lecturer in Cancer Biology and research group leader in the School of Biosciences at the University of Kent. He combines wet-lab and computational approaches, using human papillomavirus (HPV)-driven carcinogenesis as a paradigm for understanding tumour development. Work in his lab focuses on two main areas: (1) the DNA editing (APOBEC3) enzymes (his team discovered that APOBECs generate specific oncogenic mutations in HPV-associated HNSCC and other cancers, implicating them as key drivers of pathogenesis) and (2) the immune response to HPV-associated tumours – in particular how this is influenced by and in turn may influence somatic mutagenesis in tumour cells. Tim obtained his PhD in cancer biochemistry from UCL, completed postdoctoral training at the University of California, San Diego and UCL Cancer Institute, where he established his research group before taking up his faculty position at Kent in 2017. Tim’s research is supported by funding from Cancer Research UK and the Rosetrees Trust.
UNIVERSITY OF SHEFFIELD
Keith Hunter is a Professor of Head & Neck Pathology at the University of Sheffield. He completed his PhD at the Beatson Institute for Cancer Research (Glasgow) and following the completion of clinical training was appointed as Senior Clinical Lecturer and Consultant Histopathologist at the University of Glasgow. He moved to the University of Sheffield in 2009. His research has focused for over 15 years on the transcriptional changes seen in the various stages in the development of oral precancer and cancer with a particular interest in the control of cellular immortalization of oral keratinocytes. As a member of the Steering Group of the EORTC Head and Neck cancer group, he is involved in the QA of pan-European clinical trials and was also co-author of the pathology section of the 2009 Joint Practice Guidelines for Sentinel lymph node biopsy. He is the author of over 80 peer reviewed articles and has also contributed to a number of books including the 2017 WHO Classification of Tumours of the Head and Neck.
Dr. Richard Jordan is Professor of Pathology, Oral Pathology and Radiation Oncology at the University of California San Francisco (UCSF) where he is the Director of the Oral Pathology section of the UCSF Dermatopathology and Oral Pathology Service. He is also Director of the NRG Oncology Biospecimen Bank serving the biospecimen banking and translation research activities of NRG Oncology which conducts late stage phase 2 and 3 multi-institutional cancer trials in several disease sites including head & neck, lung, GU, breast, brain and the GI tract. Several major advances in the management of cancer have been reported by NRG Oncology leading to practice changing oncologic management. Dr. Jordan is also well known for the two books on oral pathology and oral medicine that he has authored. His main research interest is head & neck cancer and he has contributed over 140 peer-reviewed publications on subjects related to cancer and oral & maxillofacial pathology. He is board certified in oral & maxillofacial pathology and oral medicine in Canada and the USA. He is a Fellow of the Royal College of Pathologists.
UNIVERSITY OF MINNESOTA
Dr Ioannis Koutlas is Associate Professor in the Division of Oral and Maxillofacial Pathology at the University of Minnesota School of Dentistry, USA, and Director of the University of Minnesota Oral Pathology Laboratory. He received his DDS degree from the Faculty of Dentistry, University of Athens, Greece, and trained in Oral and Maxillofacial Pathology at the University of Minnesota where he was also granted his Masters of Science degree. He is certified by the American Board of Oral and Maxillofacial Pathology and is a Fellow of the American Academy of Oral and Maxillofacial Pathology. Dr. Koutlas has published multiple articles and book chapters in the field of Oral and Maxillofacial Pathology and has given lectures and seminars nationally and internationally. His special interests are soft tissue and bone pathology and syndromes of the head and neck, especially neurocristopathies, genodermatoses and mosaic (somatic) disorders with orofacial manifestations.
ROYAL INFIRMARY OF EDINBURGH
Dr Brendan Conn is a Consultant & Honorary Senior Lecturer in Oral/Head and Neck Pathology. He graduated with a BMSc (1999) and BDS (2002) from the University of Dundee followed by specialty training at University College Hospital & Guy’s Hospital London – obtaining FRCPath in 2010. On completion of specialist training he returned to Scotland to take up the current role which covers the South East of Scotland and the Borders. He is the Lead Pathologist for the Royal Infirmary of Edinburgh, Training Programme Director for Scotland and Dental Core Training Adviser for SE Scotland. His busy practice includes a wide variety of lesions of the oral cavity, jaws, salivary glands, sinonasal complex, nasopharynx, oropharynx, larynx, thyroid and parathyroid. He has developed a comprehensive oral and maxillofacial pathology referral practice, which serves the general pathology departments of Scotland and beyond.
Dr Martin Forster is an Associate Professor at University College London (UCL) and Consultant Medical Oncologist at UCL Hospitals NHS Foundation Trust. He specialises in Thoracic and Head & Neck cancers and has a particular interest in drug development, running a broad portfolio of studies from First-In-Human to registration Phase III trials. He is Joint Lead for the Clinical Trials Theme of the CR UK Lung Cancer Centre of Excellence and chairs the NIHR Head & Neck Research Group. He runs a research-based practice, being Principal Investigator or Chief Investigator for over 50 early and late-phase clinical trials since his appointment to UCL in 2009. These include involvement in >10 trials involving immune checkpoint inhibitors, either as single agent or in combination with a number of academic immunotherapy studies in development. He collaborates broadly with national and international groups involved in translational research. In addition, he is the UCH clinical lead for chemotherapy services and co-lead for the London Cancer Chemotherapy Expert Reference Group.
QUEEN'S UNIVERSITY, BELFAST
Dr Jackie James is a Clinical Reader / Consultant Pathologist in Molecular Diagnostics & a Co-Director for the Precision Medicine Centre of Excellence at Queen’s University Belfast. Jackie co-leads the tissue hybridization and digital pathology section of the PMC and is a member of the clinical diagnostic team delivering a regional Molecular Diagnostics service for solid tumours in Northern Ireland. Jackie has received substantial funding for digital pathology related research and is co-I on a Cancer Research UK funded Accelerator Network programme grant on Digital Molecular Pathology. She has also received funding from Innovate UK through the Industrial Strategy Challenge Fund for PathLAKE: Pathology image data Lake for Analytics, Knowledge and Exploration. Jackie secured greater than £3.5 million in recurrent funding to develop the Northern Ireland Biobank, a cancer focused Biobank, which facilitates quick, regulated access to tissue and blood samples, linked with reliable clinical and pathological data for translational cancer research. Jackie’s own research is centred on characterizing the immune contexture of cancers. She uses high quality assured tissues to identify and validate novel biomarkers for cancer predication, prognosis and response to therapy.
UNIVERSITY OF SHEFFIELD
Dr Ali Khurram is a Senior Clinical Lecturer & Consultant Pathologist at the University of Sheffield. Following his BDS (Pakistan), Masters (University of London) and PhD (University of Sheffield), he trained as a NIHR funded Academic Clinical Lecturer at Sheffield obtaining his FRCPath in 2016. He has numerous local, regional and national educational and leadership roles including Clinical lead for the Sheffield Diagnostic Oral Pathology Service. He is the Secretary and Webmaster of the British Society for Oral and Maxillofacial Pathology as well as the Digital Adviser for the Pathological Society for Great Britain and Northern Ireland. He is actively involved in research with an interest in salivary gland pathobiology, tumour microenvironment in oral cancer metastasis and bone Invasion. Over the last few years, he has been exploring the use of Machine Learning and Artificial Intelligence as aids to pathology, investigating their role in diagnosis and prediction of prognosis.
Professor Li Tie-Jun graduated from Wuhan University School of Stomatology (China) in 1984, and later obtained his PhD in the University of Birmingham Dental School (UK) in 1995. He then worked as a postdoctoral fellow in Kagoshima University Dental School (Japan) during 1995-1998. At present, he is the vice dean of Peking University School of Stomatology, professor and head of department of oral pathology. He has a long-standing research interest in the growth and behavior of odontogenic lesions of the jaws. He has won a number of academic awards throughout his career and has also been the recipient of numerous research grants from various resources. Most notably, he has been awarded National Science Fund for Distinguished Young Scholars in 2006 by the Chinese National Natural Science Foundation. To date, he has published over 100 scientific papers and has also been the editor to 6 monographs and major contributor to 7 other books.
UNIVERSITY OF TORONTO
Dr. Marco Magalhaes is the director of the Cancer Invasion and Metastasis Laboratory (CIMlab) at the Faculty of Dentistry, oral pathologist at Sunnybrook Health Sciences Centre and Assistant professor at the Faculty of Dentistry, cross-appointed to Laboratory Medicine & Pathology, Faculty of Medicine. Dr. Magalhaes received his PhD from University of Toronto in 2009 followed by postdoctoral training at the Albert Einstein College of Medicine Cancer Centre before returning to Toronto to complete his Oral Pathology & Oral Medicine Residency. Dr. Magalhaes is a member of the Network for Canadian Oral Health and Research (NCOHR) oral cancer group. His main area of interest is the progression of oral lesions and understanding how the oral microenvironment can influence malignant transformation. He is a Diplomate of the American Board of Oral and Maxillofacial Pathology, fellow of the American Academy of Oral and Maxillofacial Pathology, and a Fellow of the Royal College of Dentists of Canada.
KING'S COLLEGE LONDON
Dr John Maher is a Consultant and Senior Lecturer in Immunology. He leads the "CAR Mechanics" group within King's College London, which is focused on the development of adoptive immunotherapy using Antibody-derived chimeric antigen receptor (CAR) and gamma delta T-cells. He played a key role in the early development of second generation CAR technology and is chief investigator of a Phase 1 CAR T-cell clinical trial in head and neck cancer. He is a consultant immunologist within King's Health Partners and Eastbourne Hospital and is chief scientific officer of a CAR-T spin out company called Leucid Bio.
BELFAST HEALTH & SOCIAL CARE TRUST
Dr Séamus Napier graduated in dentistry from The Queen’s University in Belfast in 1986 and achieved a FFD from the Royal College of Surgeons in Ireland in 1990, FRCPath by examination in 1993 and PhD in 2000. He was appointed as a consultant pathologist in the Belfast Health and Social Care Trust in Belfast in 1999 where he specialises in oral/maxillofacial and head & neck pathology and is an honorary lecturer in the School of Dentistry. Dr Napier has also co-written the 2016 'Tissue Pathways for Head and Neck Pathology' guidance document for the Royal College of Pathologists, UK.
KING'S COLLEGE & GUY'S HOSPITAL, LONDON
Professor Edward Odell has been working at Guy’s Hospital in Oral and Head and Neck Pathology for over 30 years, until recently as Clinical Lead for the service and Professor of Oral Pathology and Medicine at King’s College London. He has published over 200 papers and authored or edited 5 textbooks and was a member of the WHO consensus group for the recent WHO classification of head and neck tumours. He has particular expertise in image based ploidy analysis for predicting the development of cancer in the upper digestive tract and runs the only routine pathology service for this test in the UK. He is the current President of IAOP.
UNIVERSITY OF BRITISH COLUMBIA
Dr Catherine Poh is a Professor, Faculty of Dentistry, University of British Columbia and a Senior Clinician Scientist of the Integrative Oncology Department at the BC Cancer. She is a dual certified oral pathologist in Canada and US. Being the provincial Oral Medicine Practice Leader at the BC Cancer Agency, she is also directing the mobile Oral Dysplasia Clinics in BC Hospitals. Dr. Poh’s primary research focus involves application of molecular and imaging tools for community screening, early detection, risk assessment, and management of cancerous and precancerous oral lesions.
UNIVERSITY OF WARWICK
Nasir Rajpoot is a Professor of Computational Pathology at the Computer Science department of the University of Warwick, where he started his academic career as a Lecturer in 2001. He also holds an Honorary Scientist position at the Department of Pathology, University Hospitals Coventry & Warwickshire NHS Trust. Professor Rajpoot is the founding Head of Tissue Image Analytics (TIA) laboratory at Warwick since 2012. In Autumn 2017, he was awarded the Wolfson Fellowship by the UK Royal Society and the Turing Fellowship by the Alan Turing Institute. Current focus of research in his lab is on developing algorithms for the analysis of digitised pathology images, computer-assisted grading of cancer and image-based markers for prediction of cancer progression & survival. He has been active in the digital pathology community for almost a decade now, having co-chaired several meetings in the histology image analysis (HIMA) series since 2008 and served as a founding PC member of the SPIE Digital Pathology meeting since 2012. Since January 2019, he acts as Co-Director of the £15m PathLAKE national centre of excellence on Artificial Intelligence in pathology, leading the computational arm of the centre.
UNIVERSITY OF TURKU, FINLAND
Jaana Rautava, DDS, PhD, is a specialist in oral pathology and an associate professor of oral pathology and oral medicine. She is currently working as an acting professor of oral pathology at the University of Turku, Turku, Finland and senior lecturer/researcher at the University of Helsinki, Helsinki, Finland. She is actively involved in the running of the Oral pathology service at HUSLAB, Helsinki University Hospital, Helsinki, Finland. Her special interest include diagnostics and treatment of patients with oral mucosal diseases. Her primary research focus is on malignant transformation of potentially malignant oral lesions.
UNIVERSITY OF OTAGO, NEW ZEALAND
Alison Rich is the Professor of Oral Pathology at the University of Otago, New Zealand. She is a registered specialist in oral pathology and is Head of the Oral Pathology Centre, the University’s oral pathology diagnostic service and the Leader of the Oral Immunopathology Research Group. She is a previous Chair of the Faculty of Oral and Maxillofacial Pathology of the Royal College of Pathologists of Australasia and their current Chief Examiner.
CENTRE LÉON BÉRARD, LYON
Pierre Saintigny is a physician-scientist at Centre Léon Bérard, Lyon, France. He is heavily involved in the development of translational research programs. He is affiliated to the Department of Medical Oncology and is team leader at Cancer Research Center of Lyon. He coordinates the platform of Genomics, the platform of Bioinformatics-Gilles Thomas, the platform of Pathology Research, a platform for ex-vivo models and the Centre Léon Bérard certified Biobank. He was trained both in Paris and at MD Anderson Cancer Center in Houston, TX as a postdoctoral fellow and clinical fellow under the mentorship of L Mao, SM Lippman (founding editor of the Cancer Prevention Research journal of the AACR and co-leader of the NCI PreCancer Atlas) and WK Hong who both helped establish the concept of chemoprevention, and was promoted as an Assistant Professor. In the fall of 2013, he accepted a new position at Centre Léon Bérard and initiated the “Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With oral potentially malignant lesions or head and neck squamous cell carcinoma” (NCT03276819). He is co-leading with Christine Chomienne the Cancer French Task Force on Preneoplasia with the goal to set up an action plan to address and bolster preneoplasia research.
ALAN ROGER DOS SANTOS-SILVA
Dr. Santos-Silva received his DDS at The São Paulo State University, Brazil. He completed a MSc program in Oral Medicine and a PhD program in Pathology at The University of Campinas (UNICAMP), Brazil. He underwent Doctoral Externship in Oral & Maxillofacial Pathology at The University of Sheffield, UK. Dr. Santos-Silva served as coordinator of the Graduation Program in Oral Medicine and Pathology at UNICAMP where he currently holds the position of Associate Professor in the Department of Oral Diagnosis. He has publications in peer review journals and book chapters on the topics of Oral Pathology and Oral Medicine.
MERVA SOLUK TEKKESIN
Merva Soluk Tekkesin is an Associate Professor of Oral & Maxillofacial Pathology at Istanbul University, Institute of Oncology, Department of Tumour Pathology since 2015. She completed her dental training in 2003, residency in Oral & Maxillofacial Pathology, as well as her Ph.D., was completed in Tumour Pathology at Istanbul University in 2010. Dr. Soluk Tekkesin was an overseas training fellow with GDC registration at King’s College London, Guy’s Hospital for 7 months between 2009 - 2010. She was the first Tier 5 International Training Fellow to complete training in the United Kingdom. Dr Soluk Tekkesin was the secretary of Head and Neck Working Group in Turkey between 2010- 2014. She has served as European Councilor of International Association of Oral and Maxillofacial Pathologists- IAOP since 2014. She has numerous high-quality publications and book chapters, including contribution to the 2017 4th edition of World Health Organization of Head and Neck Tumors. Dr Soluk Tekkesin has been assigned a ‘Visiting Professor’ by Tehran University of Medical Sciences until 2021.
KING'S COLLEGE & GUY'S HOSPITAL, LONDON
Dr Selvam Thavaraj obtained his Bachelor of Dental Science (BDS) degree at United Medical & Dental Schools, Guy’s Hospital in 1994. Following a period of general dental practice and hospital dentistry, he then gained a Doctor of Philosophy (PhD) in oral carcinogenesis from Bristol University in 2005. He then went on to undertake higher specialist training in Oral & Maxillofacial Surgery in London and was awarded the Fellowship of the Royal College of Pathologists (FRCPath) in 2009. He was appointed at King’s College London and Guy’s & St Thomas’ NHS Foundation Trust in in the same year and is part of the histopathology service for one of the largest head and neck cancer treatment centres in the United Kingdom. His research interests include various aspects of human papillomavirus associated head and neck cancer, sentinel node evaluation in oral cancer and various aspects of biomarkers in premalignancy and cancer.
UNIVERSITY OF SOUTHAMPTON
Professor Gareth Thomas is Chair of Experimental Pathology at the University of Southampton and a Consultant in Head and Neck Pathology. His laboratory focuses on the tumour immune microenvironment, particularly the role of cancer-associated fibroblasts (CAF) in promoting tumour progression. The translational aspect of the work has an emphasis on mechanisms regulating CAF differentiation and interactions with immune cells, identifying potential predictive biomarkers and druggable targets to develop strategies to improve immunotherapy.
TEL AVIV UNIVERSITY
Marilena Vered obtained her dental degree (DMD) at the Faculty of Dentistry, at the Hebrew University in Jerusalem. After graduation, she started the Oral Pathology training program at the Department of Oral Pathology and Oral Medicine, at the School of Dentistry at Tel Aviv University and finished in 2001. She is currently the Head of this department. She is also in charge of the service of oral pathology at the Sheba Medical Center at Tel Hashomer, which has been ranked by the Newsweek Magazine, as one of the 10 leading medical centers in the world for 2019. She has co-authored over 100 articles in international peer-reviewed journals and serves as a reviewer for most of the leading journals in the field of oral pathology and medicine. She has been interested in investigating the microenvironment of oral cancer and collaborated with leading researchers in this field. In addition, she has published on several rare and challenging odontogenic lesions.
TEXAS A&M UNIVERSITY
Dr. John M. Wright is Regents Professor, Department of Diagnostic Sciences, Texas A&M University College of Dentistry in Dallas, Texas. He is an oral pathologist and a Diplomate of both the American Board of Oral and Maxillofacial Pathology and the American Board of Oral Medicine. He received his dental degree from West Virginia University and oral pathology training at Indiana University. He has contributed over 180 publications to the scientific literature, as well as 25 book chapters and three textbooks. Dr. Wright is a past President of the American Academy of Oral and Maxillofacial Pathology, the American Board of Oral and Maxillofacial Pathology and the International Association of Oral Pathologists. Dr. Wright has participated in over 400 statewide, national and international programs.